Skip to main content
. 2020 Sep 9;74(9):589–595. doi: 10.1136/jclinpath-2020-206457

Table 3.

LAT1 and CD98hc scores in all cases and various category

Subtype LAT1 score CD98hc score
N 0 1 2 3 4 6 9 Median (IQR) 0 1 2 3 4 6 9 Median (IQR)
All cases 280 54 21 20 52 5 47 81 3 (1–9) 23 30 17 63 13 56 78 4 (2.8–9)
TNBC 78 2 3 0 8 2 15 48 9 (6–9)* 3 4 2 6 6 15 42 9 (4–9)*
NTNBC 202 52 18 20 44 3 32 33 3 (0–6)* 20 26 15 57 7 41 36 3 (2–6)*
 Luminal A 151 45 17 18 33 3 20 15 2 (0–3.5) 17 24 12 50 7 25 16 3 (1–6)
 Luminal B 17 3 0 2 5 0 4 3 3 (2–6) 1 1 2 3 0 4 6 6 (3–9)
 HER2 34 4 1 0 6 0 8 15 6 (3–9) 2 1 1 4 0 12 14 6 (6–9)

*P value <0.0001.

HER2, human epidermal growth factor receptor-2; LAT1, L-type amino acid transporter1; NTNBC, non-triple-negative breast cancer; TNBC, triple-negative breast cancer.